Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies.
Jon Jin KimOlivia ShawChloe MartinGeorge MichaelidesRamnath BalasubramaniamNeil J SebireNizam MamodeAnthony DorlingRobert VaughanStephen D MarksPublished in: Pediatric nephrology (Berlin, Germany) (2017)
Assessment of C3d fixing as part of prospective HLA monitoring can potentially aid stratification of patients at the highest risk of long-term renal allograft dysfunction.